reduce basal insulin when starting glp-1 receptor agonist glp-1_analogs [TUSOM Frontiers | Exploring the multifaceted
Description
Wyse is the visionary behind the International Linked Clinical Trials (LCT) program, which aims to prioritize potential disease-modifying compounds for Parkinsons treatment
doi: 10.1016/j.immuni.2021.04.022 98 WongCKMcLeanBABaggioLLKoehlerJAHammoudRRittigNet al
Behavioral conditioned responses to contextual and odor stimuli paired with LiCl administration
Noyan-Ashraf MH, Shikatani EA, Schuiki I, Mukovozov I, Wu J, Li RK, Volchuk A, Robinson LA, Billia F, Drucker DJ, et al
Checking multiple pharmacies and online programs may reveal better pricing options for GLP-1 medications
